142 related articles for article (PubMed ID: 35546514)
1. Evaluation of a long-acting injectable formulation of omeprazole in healthy dogs.
Odunayo A; Galyon G; Price J; Hecht S; Tolbert MK
J Vet Intern Med; 2022 Jul; 36(4):1416-1421. PubMed ID: 35546514
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized, masked, placebo-controlled crossover study for the effect of 10 mg omeprazole capsules on gastric pH in healthy dogs.
Gaier A; Price J; Grubb L; Fitzgerald S; Tolbert MK
J Vet Intern Med; 2021 Mar; 35(2):887-891. PubMed ID: 33586200
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs.
Tolbert K; Bissett S; King A; Davidson G; Papich M; Peters E; Degernes L
J Vet Intern Med; 2011; 25(1):47-54. PubMed ID: 21143305
[TBL] [Abstract][Full Text] [Related]
4. Preliminary investigations into a novel, long-acting, injectable, intramuscular formulation of omeprazole in the horse.
Sykes BW; Kathawala K; Song Y; Garg S; Page SW; Underwood C; Mills PC
Equine Vet J; 2017 Nov; 49(6):795-801. PubMed ID: 28397996
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effect of a famotidine continuous rate infusion on intragastric pH in healthy dogs.
Hedges K; Odunayo A; Price JM; Hecht S; Tolbert MK
J Vet Intern Med; 2019 Sep; 33(5):1988-1994. PubMed ID: 31294879
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs.
Kuhl A; Odunayo A; Price J; Hecht S; Marshall K; Steiner J; Tolbert MK
J Vet Intern Med; 2020 Mar; 34(2):678-683. PubMed ID: 32020689
[TBL] [Abstract][Full Text] [Related]
7. Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs.
Bersenas AM; Mathews KA; Allen DG; Conlon PD
Am J Vet Res; 2005 Mar; 66(3):425-31. PubMed ID: 15822586
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effect of orally administered acid suppressants on intragastric pH in cats.
Parkinson S; Tolbert K; Messenger K; Odunayo A; Brand M; Davidson G; Peters E; Reed A; Papich MG
J Vet Intern Med; 2015 Jan; 29(1):104-12. PubMed ID: 25537303
[TBL] [Abstract][Full Text] [Related]
9. The frequency of oral famotidine administration influences its effect on gastric pH in cats over time.
Golly E; Odunayo A; Daves M; Vose J; Price J; Hecht S; Steiner JM; Hillsman S; Tolbert MK
J Vet Intern Med; 2019 Mar; 33(2):544-550. PubMed ID: 30746763
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of intravenous administration of combined acid suppressants in healthy dogs.
Tolbert MK; Odunayo A; Howell RS; Peters EE; Reed A
J Vet Intern Med; 2015; 29(2):556-60. PubMed ID: 25711717
[TBL] [Abstract][Full Text] [Related]
11. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
Ĺ utalo S; Ruetten M; Hartnack S; Reusch CE; Kook PH
J Vet Intern Med; 2015; 29(3):840-6. PubMed ID: 25966746
[TBL] [Abstract][Full Text] [Related]
12. Repeated Famotidine Administration Results in a Diminished Effect on Intragastric pH in Dogs.
Tolbert MK; Graham A; Odunayo A; Price J; Steiner JM; Newkirk K; Hecht S
J Vet Intern Med; 2017 Jan; 31(1):117-123. PubMed ID: 27906465
[TBL] [Abstract][Full Text] [Related]
13. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.
Tutuian R; Katz PO; Ahmed F; Korn S; Castell DO
Aliment Pharmacol Ther; 2002 Mar; 16(3):473-7. PubMed ID: 11876700
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects.
Williams MP; Sercombe J; Hamilton MI; Pounder RE
Aliment Pharmacol Ther; 1998 Nov; 12(11):1079-89. PubMed ID: 9845397
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of intravenous esomeprazole at 2 different dosages in dogs.
Seo DH; Lee JB; Hwang JH; Jeong JW; Song GH; Koo TS; Seo KW
J Vet Intern Med; 2019 Mar; 33(2):531-535. PubMed ID: 30548689
[TBL] [Abstract][Full Text] [Related]
16. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
Miner PB; Allgood LD; Grender JM
Aliment Pharmacol Ther; 2007 Jan; 25(1):103-9. PubMed ID: 17229225
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
Takeda H; Hokari K; Asaka M
J Clin Gastroenterol; 1995; 20 Suppl 1():S7-9. PubMed ID: 7673616
[TBL] [Abstract][Full Text] [Related]
18. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
Abe Y; Inamori M; Togawa J; Kikuchi T; Muramatsu K; Chiguchi G; Kawamura H; Kobayashi N; Kirikoshi H; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
J Gastroenterol; 2004 Jan; 39(1):21-5. PubMed ID: 14767730
[TBL] [Abstract][Full Text] [Related]
19. Effects of rabeprazole, lansoprazole and omeprazole on intragastric pH in CYP2C19 extensive metabolizers.
Saitoh T; Fukushima Y; Otsuka H; Hirakawa J; Mori H; Asano T; Ishikawa T; Katsube T; Ogawa K; Ohkawa S
Aliment Pharmacol Ther; 2002 Oct; 16(10):1811-7. PubMed ID: 12269976
[TBL] [Abstract][Full Text] [Related]
20. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.
Katz PO; Hatlebakk JG; Castell DO
Aliment Pharmacol Ther; 2000 Jun; 14(6):709-14. PubMed ID: 10848653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]